Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination with Efavirenz Or Atazanavir/Ritonavir for Treatment-Naive Adults with Hiv-1 Infection in the United Kingdom
Citation
Wilkins, E., Fisher, M., Brogan, A., & Talbird, S. (2014). Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination with Efavirenz Or Atazanavir/Ritonavir for Treatment-Naive Adults with Hiv-1 Infection in the United Kingdom. Value in Health, 17(3), A276-A276.